Home
Categories
Pharmaceutical
Hi Tech Manufacturing
Food
Finance
Design & Build
Containment
Cleaning
Sustainability
HVAC
Personal Protection
Regulatory
CT CONFERENCE
Company News
Events
Directory
Search
Close search
Home
Company
Helsinn Group
Helsinn Group
Activities:
Design & Build
HVAC
Research & Development
Analysis
X
LinkedIn
Trending Articles
In wake of COVID-19 Medicom opens €88m nitrile glove facility in France
The PPE provider has opened the facility in response to Europe's dependence on nitrile glove imports, as revealed by the Covid-19 pandemic in 2020
IPS opens new branches in the UK and US
US-based IPS (Integrated Project Service) has expanded its reach by opening new branches in Alderley Park and Texas
What is ISO 8 cleanroom classification?
Each cleanroom class is denoted by a maximum concentration of particles per cubic meter or cubic foot of air. ISO 8 is the second lowest cleanroom classification
Impact of the new Annex 1 on sterile filling in pharma
EU GMP Annex 1 is a whole new era for the sterile filling industry. From barrier technology to “first air”, pharmaceutical manufacturers have a lot to decide. Johannes...
Medhini Group announces partnership with sustainable engineering consultancy
Medhini Group and TERAO Asia have joined forces to advance sustainable and green industrial projects in Malaysia
Upcoming event
Clinical Pharmacy Congress
10-11 May 2024 | Conference | London, UK
See all
Related Content
You need to be a subscriber to read this article.
Click here
to find out more.
Containment
Containment for cytotoxics
The increasing potency of active pharmaceutical ingredients is driving the requirement for more advanced containment systems to ensure operator safety at both pilot scale and for large-scale commercial production
Containment
PSL shows groundbreaking high containment filter dryer at ACHEMA
Powder Systems Ltd (PSL) supports the expansion of Helsinn Advanced Synthesis into the cytotoxic market with its revolutionary contained filtration and drying technology
Containment
PSL to supply FilterBoxes to new Helsinn facility
The trend towards increasingly potent products will cause production, cleaning and safety issues
Manufacturing
Helsinn to build €15.4m cytotoxic plant in Switzerland
Will start commissioning laboratory projects in 2012
Subscribe now